Blogs about: Afexa Life Sciences Inc

Featured Blog

Valeant pulls bid for ISTA Pharmaceuticals

Reuters wrote 1 year ago: TORONTO — Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeov … more →

Tags: Investing, Mergers and Acquisitions, Valeant Pharmaceuticals International, Pharmaceuticals Sector

Valeant launches hostile bid for ISTA Pharmaceuticals

Reuters wrote 1 year ago: TORONTO — Valeant Pharmaceuticals International Inc said on Friday it has submitted an unsolicited U … more →

Tags: Investing, Mergers and Acquisitions, Valeant Pharmaceuticals International Inc

Opening Bell: North American markets extend losses

Christine Dobby wrote 1 year ago: Following on heavy losses at the end of Monday’s trading session, U.S. markets were initially … more →

Tags: Europe, blackberry, RIM, China, NASDAQ, Gold, S&P 500, Stocks, France

Valeant gains control of Cold-FX maker; extends offer

Christine Dobby wrote 1 year ago: Valeant Pharmaceuticals International Inc. said Tuesday it has taken control of Afexa Life Sciences … more →

Tags: Mergers and Acquisitions, corporate news, Valeant Pharmaceuticals International Inc, cold fx, Paladin Labs Inc.

Paladin drops out of battle for Cold-FX

Christine Dobby wrote 1 year ago: The battle for Cold-FX maker Afexa Life Sciences Inc. appears to be coming to an end as one of its r … more →

Tags: Investing, corporate news, Valeant Pharmaceuticals International Inc, cold fx, Paladin Labs Inc.

Cold-FX bidding war heats up

Eric Lam wrote 1 year ago: The bidding war for Cold-FX flu remedy maker Afexa Life Sciences Inc. is getting hot and heavy, with … more →

Tags: Investing, corporate news, Valeant Pharmaceuticals International Inc, cold fx, Paladin Labs Inc.

Afexa finds white knight in Valeant

Nicolas Van Praet wrote 1 year ago: MONTREAL — Cold-FX maker Afexa Life Sciences Inc. has found a white knight to fend off a hostile bid … more →

Tags: M&A, corporate news, Valeant Pharmaceuticals International Inc, biovail corp, cold fx, Paladin Labs Inc.

Cold-FX maker has failed to deliver on promises: Paladin

Nicolas Van Praet wrote 1 year ago: MONTREAL — Millions of people around the world are constantly getting sore throats and runny n … more →

Tags: corporate news, Pharmaceuticals, Research and Development, cold fx, Paladin Labs Inc.

Reject Paladin offer: Afexa board to shareholders

Christine Dobby wrote 1 year ago: Firing the latest salvo in a heated Canadian pharmaceutical battle, Afexa Life Sciences Inc.’s … more →

Tags: Takeover, Labopharm Inc, corporate news, Pharmaceuticals, cold fx, Paladin Labs Inc.

Paladin Labs on buying spree with friendly $20.4M Labopharm deal

Christine Dobby wrote 1 year ago: Pharmaceutical company Paladin Labs Inc. continued its buying spree Wednesday, announcing plans to a … more →

Tags: trading desk, Labopharm Inc, Pharmaceuticals, Paladin Labs Inc.

Paladin announces hostile bid for remaining shares of COLD-FX makers

Christine Dobby wrote 1 year ago: Following the break down of friendly talks with Afexa Life Sciences Inc., Paladin Labs Inc. has laun … more →

Tags: Investing, takeovers, Pharmaceuticals, cold fx, Paladin Labs Inc.

Paladin Labs takes stake in COLD-FX maker

Christine Dobby wrote 1 year ago: COLD-FX has another believer in Paladin Labs Inc., which announced an equity investment in Afexa Lif … more →

Tags: trading desk, Pharmaceuticals, Paladin Labs, afexa life sciences, cold fx, Paladin Labs Inc.


Related Tags
All →

Follow this tag via RSS